Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001516551-24-000119
Filing Date
2024-11-20
Accepted
2024-11-20 08:23:53
Documents
1
Period of Report
2024-11-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1732109026.html 4  
1 FORM 4 wk-form4_1732109026.xml 4 5438
  Complete submission text file 0001516551-24-000119.txt   7176
Mailing Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130
Business Address 11250 EL CAMINO REAL, SUITE 100 SAN DIEGO CA 92130 (858) 410-0266
Skye Bioscience, Inc. (Issuer) CIK: 0001516551 (see all company filings)

EIN.: 450692882 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11250 EL CAMINO REAL SUITE 100 SAN DIEGO CA 92130
Business Address
Diep Tuan Tu (Reporting) CIK: 0002013809 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42009 | Film No.: 241478341